首页> 外国专利> METHOD FOR SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY HEMOPHTHALMOS AND TRACTION RETINA DETACHMENT

METHOD FOR SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY HEMOPHTHALMOS AND TRACTION RETINA DETACHMENT

机译:增生性视网膜炎合并牵引性视网膜脱离的糖尿病性增生性视网膜病变的手术治疗方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, specifically to ophthalmology. For treating proliferative diabetic retinopathy (PDR) complicated by hemophthalmos and traction retinal detachment, ports for manipulating surgical instruments are installed, for cannula with supply of balanced irrigation physiological solution, for constant installation of chandelier. That is followed by removal of vitreous body with separation of posterior hyaloid membrane from retina with frequency of cuts of 8000 per minute, vacuum of 650 mm Hg. At that, as the vitreous cutter approaches the retina and fibroglial tissue, the vacuum is reduced to 350 mm Hg, and the cuts are switched to the "razor" mode. Then fibroglial tissue is removed with tweezers and vitreous cutter, or with tweezers and endovitral shears, or with diathermocoagulation and scissors. After removal of fibroglial tissue using sclerocompressor and vitreous cutter bimanual remove hyaloid tissue and bleeding from extreme periphery of retina. It involves endolaser coagulation of retina of 0.16–0.18 mW along the vascular arcades and at the extreme periphery up to the dentate line. Silicone or gas-air mix is used to tamponade the vitreal cavity. At the end of the operation, four transconjunctival sutures are applied at the port installation site.;EFFECT: method reduces risk of iatrogenic ruptures, reduces traction effect on retina and reduces damage of vitreoretinal interface structures as a whole.;1 cl, 3 ex
机译:技术领域本发明涉及医学,尤其涉及眼科。为了治疗并发眼炎和视网膜脱离性视网膜病变的增生性糖尿病视网膜病变(PDR),安装了用于操纵手术器械的端口,为插管提供了平衡的灌溉生理溶液,并不断安装了枝形吊灯。然后通过从视网膜分离后玻璃状膜去除玻璃体,切割频率为每分钟8000次,真空度为650 mm Hg。那时,随着玻璃体切割器接近视网膜和纤维胶质组织,真空降低到350 mm Hg,并且切割被切换到“剃刀”模式。然后用镊子和玻璃体切割器,镊子和内膜剪,或透热凝结和剪刀除去纤维胶质组织。使用硬化压迫器和玻璃体切割器切除纤维胶质组织后,双手切除玻璃样组织并从视网膜的极端边缘出血。它涉及沿血管拱廊以及在到齿状线的最边缘处,视网膜内激光凝结0.16-0.18 mW的视网膜。硅树脂或气体-空气混合物用于填充玻璃体腔。手术结束时,在港口安装现场应用了四次结膜缝合。效果:该方法降低了医源性破裂的风险,降低了对视网膜的牵引作用,并减少了整个玻璃体视网膜界面结构的损伤。; 1 cl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号